For this purpose, we used UALCAN, GENT2, and HPA databases, as well as the Kaplan–Meier (KM) plotter tool to analyze and validate CTHRC1 expression and its correlation with the prognosis of distinct cancer subtypes. The gene discussed is CTHRC1; the disease is cancer.